Cancer Genetics Inc (NASDAQ:CGIX)

7.69
Delayed Data
As of 12:36pm ET
 +0.13 / +1.72%
Today’s Change
4.83
Today|||52-Week Range
16.88
+15.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues3.0M4.3M6.6M10.2M
 
 
 
 
 
Cost of Goods Sold2.7M3.6M4.6M8.5M
 
 
 
 
 
Depreciation And Amortization369.7K353.4K326.5K--
 
 
 
 
 
Operating ExpensesGross Income-98.0K372.6K1.7M1.7M
 
 
 
 
 
General Expenses8.1M8.0M9.5M21.0M
 
 
 
 
 
Research And Development2.1M2.1M2.2M4.6M
 
 
 
 
 
Total Operating Expenses11.2M11.9M14.5M29.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.2M-7.6M-7.8M-19.2M
 
 
 
 
 
Extraordinary Credit0.007.5M4.6M615.0K
 
 
 
 
Extraordinary Charge-10.4M-1.9M-7.5M0.00
 
 
 
 
Interest Expense On Debt1.3M4.7M2.4M472.8K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.9M-6.7M-13.0M-19.0M
 
 
 
 
 
Income Taxes0.000.00-663.9K-2.4M
 
 
 
Net Income-19.9M-6.7M-12.4M-16.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.0M4.0M4.7M9.4M
 
 
 
 
 
Shares To Calculate EPS Diluted4.0M4.0M4.7M9.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$15.61-$10.55-$3.64-$1.80
 
 
 
 
 
EPS Diluted-$4.95-$3.54-$3.64-$1.80
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account